MedTrace Logo

Long-term Outcomes for Acute Myeloid Leukemia Patients

NCT03755856 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 343

Last updated 2020-03-04

No results posted yet for this study

Summary

This international observational study aims at examining the patterns of health-related quality of life differences between long-term acute myeloid leukemia patients and their healthy peers from the general population.

Conditions

Interventions

OTHER

Questionnaire

Health-related quality of life

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    collaborator NETWORK

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Fabio Efficace · GIMEMA Foundation

  • Frédéric Baron · European Organisation for Research and Treatment of Cancer - EORTC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-16
Primary Completion
2021-06-30
Completion
2022-12-31

Countries

  • Belgium
  • Croatia
  • France
  • Italy
  • North Macedonia
  • Slovakia
  • Slovenia
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03755856 on ClinicalTrials.gov